Expertise in
4
conditions

Dr. Michael G. Miller

Endocrinology
MyMichigan Medical Center Midland
4000 Wellness Dr, 
Midland, MI 
Expertise in
4
conditions
MyMichigan Medical Center Midland
4000 Wellness Dr, 
Midland, MI 

Overview

Michael Miller is an Endocrinologist practicing medicine in Midland, Michigan.

Dr. Miller is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Isolated Hypogonadotropic Hypogonadism, Hypogonadotropic Hypogonadism, Hypogonadism, Abdominal Obesity Metabolic Syndrome, and Hormone Replacement Therapy (HRT).

He is actively involved in clinical research, co-authoring 49 peer reviewed articles and participating in 6 clinical trials.

Specialties

Endocrinology

Licenses

Internal Medicine in MI

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO

Locations

MyMichigan Medical Center Midland
4000 Wellness Dr, Midland, MI 48670

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Randomized Double-blind, Placebo-controlled, Multicenter Trial Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With Established Cardiovascular Disease
A Randomized Double-blind, Placebo-controlled, Multicenter Trial Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With Established Cardiovascular Disease
Enrollment Status: Completed
Publish Date: August 28, 2026
Intervention Type: Drug
Study Drug: TQJ230
Study Phase: Phase 3
Non-invasive Rapid Assessment of Non-alcoholic Fatty Liver Disease (NAFLD) Using Magnetic Resonance Imaging With LiverMultiScan (RADIcAL1)
Non-invasive Rapid Assessment of Non-alcoholic Fatty Liver Disease (NAFLD) Using Magnetic Resonance Imaging With LiverMultiScan (RADIcAL1)
Enrollment Status: Completed
Publish Date: August 22, 2023
Intervention Type: Diagnostic test
Study Phase: Not Applicable
Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Arm, 12-week Study to Evaluate the Safety and Efficacy of Saroglitazar Magnesium 1, 2 and 4 mg in Patients With Fasting Triglyceride ≥500 mg/dL and ≤1500 mg/dL
Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Arm, 12-week Study to Evaluate the Safety and Efficacy of Saroglitazar Magnesium 1, 2 and 4 mg in Patients With Fasting Triglyceride ≥500 mg/dL and ≤1500 mg/dL
Enrollment Status: Suspended
Publish Date: February 08, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Double-Blind, Randomized, Placebo-Controlled Clinical Trial to Assess the Efficacy & Safety of Oral GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodeoxycholic Acid and With Persistently Elevated Alkaline Phosphatase
A Double-Blind, Randomized, Placebo-Controlled Clinical Trial to Assess the Efficacy & Safety of Oral GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodeoxycholic Acid and With Persistently Elevated Alkaline Phosphatase
Enrollment Status: Completed
Publish Date: June 29, 2022
Intervention Type: Drug
Study Phase: Phase 2
A 12-Week, Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy Safety and Tolerability of Gemcabene in Subjects With Severe Hypertriglyceridemia (INDIGO-1)
A 12-Week, Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy Safety and Tolerability of Gemcabene in Subjects With Severe Hypertriglyceridemia (INDIGO-1)
Enrollment Status: Completed
Publish Date: June 25, 2020
Intervention Type: Drug
Study Phase: Phase 2
Metabolic Actions of Omega-3 Fatty Acids on Inflammation and Adipocyte Lipolysis in the Metabolic Syndrome
Metabolic Actions of Omega-3 Fatty Acids on Inflammation and Adipocyte Lipolysis in the Metabolic Syndrome
Enrollment Status: Completed
Publish Date: January 14, 2020
Intervention Type: Dietary supplement
Study Phase: Not Applicable
View 5 Less Clinical Trials

49 Total Publications

Pharmacokinetic profiling of limnetrelvir in non-Japanese and Japanese populations: results of two phase 1 single- and multiple-dose studies.
Pharmacokinetic profiling of limnetrelvir in non-Japanese and Japanese populations: results of two phase 1 single- and multiple-dose studies.
Journal: Antimicrobial agents and chemotherapy
Published: March 23, 2026
Similar Doctors
Expertise in
41
conditions
Dr. Sujay Madduri
Endocrinology
Expertise in
41
conditions
Dr. Sujay Madduri
Endocrinology
Referral required
Before you request

My Michigan Health Diabetes/Nutrition Services-Midland

301 W Wackerly St, 
Midland, MI 
 (2.1 miles away)
989-488-5850
Languages Spoken:
English, Hindi, Malayalam, Telugu
See accepted insurances
Accepting New Patients
Offers Telehealth

Sujay Madduri is an Endocrinologist practicing medicine in Midland, Michigan. Dr. Madduri is highly rated in 41 conditions, according to our data. His clinical expertise encompasses Type 1 Diabetes (T1D), Hyperthyroidism, Diabetic Neuropathy, and Medullary Thyroid Carcinoma. Dr. Madduri is currently accepting new patients.

Expertise in
38
conditions
Dr. Loabat Amiri
Endocrinology
Expertise in
38
conditions
Dr. Loabat Amiri
Endocrinology
Referral required
Before you request

Office

4201 Campus Ridge Dr Ste 3200, 
Midland, MI 
 (5.3 miles away)
989-488-5850
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Loabat Amiri is an Endocrinologist practicing medicine in Midland, Michigan. Dr. Amiri is highly rated in 38 conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Thyroid Cancer, Anaplastic Thyroid Cancer, and Thyroid Storm. Dr. Amiri is currently accepting new patients.

Expertise in
40
conditions
Dr. Amer Issa
Endocrinology
Expertise in
40
conditions
Dr. Amer Issa
Endocrinology
Referral required
Before you request

Lifetime Family Healthcare PLLC

4801 McLeod Dr E, 
Saginaw, MI 
 (18.4 miles away)
989-607-0809
Languages Spoken:
English, Arabic
See accepted insurances
Accepting New Patients
Offers Telehealth

Amer Issa is an Endocrinologist practicing medicine in Saginaw, Michigan. Dr. Issa is highly rated in 40 conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Thyroid Storm, Type 1 Diabetes (T1D), and Hypothyroidism. Dr. Issa is currently accepting new patients.

Frequently Asked Questions about Dr. Michael G. Miller

How do I make an appointment with Dr. Michael G. Miller?

You can book an appointment with Dr. Michael G. Miller by calling their office at 989-839-3000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Michael G. Miller a top-rated expert for Isolated Hypogonadotropic Hypogonadism?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Michael G. Miller is classified as an Distinguished expert for Isolated Hypogonadotropic Hypogonadism, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Michael G. Miller specialize in?

While Dr. Michael G. Miller is a Endocrinology, they have specific expertise in Isolated Hypogonadotropic Hypogonadism, Hypogonadotropic Hypogonadism, and Hypogonadism. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Endocrinology.

Does Dr. Michael G. Miller participate in research or clinical trials?

Yes. Dr. Michael G. Miller has published 49 articles and abstracts on conditions like Isolated Hypogonadotropic Hypogonadism. You can view a list of Dr. Michael G. Miller's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Michael G. Miller accept my insurance?

Dr. Michael G. Miller accepts most major insurance plans, including Blue Cross Blue Shield and Health Care Services Corporation. We recommend calling the office directly at 989-839-3000 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Miller's expertise for a condition
ConditionClose
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile